AzTrials
AzTrials

ObesityPhase 2THRIVENCT06028113

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

A Phase 2 study testing THRIVE 2.0 in people with Obesity and Obesity, Childhood, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to test a responsive parenting obesity prevention program with infants and caregivers of color (e.g., non-White; Hispanic/Latinx) and/or who are economically marginalized (i.e., publicly insured), delivered via Integrated Behavioral Health (IBH) in pediatric primary care. Read more about this study

Who is it for?
Ages 1 day and olderHealthy volunteers can take part
Conditions the study is for
Obesity, Obesity, Childhood, Weight Gain
What is being tested?
THRIVE 2.0
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteUnited States
Study dates
5 Oct 2023to 30 Jan 2026
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • born 2500 grams or greater
  • delivery occurring between 37 and 42 weeks gestation
  • English speaking
  • infant receiving care provided at our pediatric primary care setting
  • from a racial / ethnic minority group (i.e., non-white, or Hispanic or Latinx) and/or economically marginalized background (i.e., household income at or below 138% of federal poverty level; qualifying for Medicaid)

Who cannot join

  • care in the Neonatal Intensive Care Unit (>7 days)
  • infant congenital anomaly or neonatal condition that affects feeding (e.g., cleft lip/palate, metabolic disease)
  • infant exposure to illicit drugs in utero [with the exception of tetrahydrocannabinol (THC)]
  • diminished or impaired caregiver cognitive functioning
  • family intent to move from the area within 1 year

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tiffany Rybak, PhD contact

513-517-7254

tiffany.rybak@cchmc.org

Sarah Francis, PhD contact

513-803-2605

sarah.francis@cchmc.org

United States1 site, 1 recruiting
  • Hopple Street Neighborhood Health Center

    Cincinnati, Ohio, 45225

    Sarah Francis, sarah.francis@cchmc.org

    Recruiting

Other trials in United States

About this study

Official title: A Novel Obesity Prevention Program for High-Risk Infants in Pediatric Primary Care: The THRIVE Randomized Controlled Trial

The goal of this clinical trial is to test a responsive parenting obesity prevention program with infants and caregivers of color (e.g., non-White; Hispanic/Latinx) and/or who are economically marginalized (i.e., publicly insured), delivered via Integrated Behavioral Health (IBH) in pediatric primary care. The main questions it aims to answer are:

  • 1) Is the obesity prevention intervention delivered via IBH in pediatric primary care feasible and acceptable to families of color and/or families who are economically marginalized?
  • 2) Will it prevent rapid weight gain during infancy?

Participants will complete baseline (newborn), post-treatment (9 months), and follow-up assessments (12 months). Participants assigned to treatment will receive 4 prevention sessions as part of their typical well-child visit in pediatric primary care. Researchers hypothesize that infants in the obesity prevention intervention will have stable weight gain compared to infants in the control group (treatment as usual) will experience more rapid weight gain.

Read the detailed description

Unprecedented rates of obesity are occurring in childhood and disproportionally affect Black or African American youth, Hispanic or Latinx youth, and youth from economically marginalized backgrounds beginning as early as infancy. Obesity in infancy is not outgrown, tracks into adulthood, and places infants and children with obesity at a higher risk for significant medical comorbidities (e.g., cardiometabolic complications) in adulthood. The healthcare cost of obesity is ~$260 billion annually across the lifespan. Recent evidence suggests that infancy may be a critical period for the development of this high weight trajectory, as 10% of infants meet criteria for high weight-for-length; with the incidence being even higher among infants of color (16.3%), infants of Hispanic/Latinx ethnicity (12.1%), and economically marginalized infants (12.2%). Several modifiable predictors of obesity risk have been identified in infancy, including rapid weight gain in the first year, parental use of food to regulate infant distress, early introduction to solid foods, and insufficient infant total cumulative sleep. Given the greater risk for obesity, there is a critical need to identify and improve access to the most effective obesity prevention treatments for this population as a means of reducing the long-term healthcare burden.

This pilot RCT will compare a responsive parenting intervention to treatment as usual in pediatric primary care with 144 infants who are from communities of color (e.g., non-White; Hispanic or Latinx) and/or economically marginalized backgrounds (i.e., publicly insured). Families will receive four prevention sessions with the integrated behavioral health specialist at their routine primary care well-child visits during the first six months of life. The primary outcome measured is conditional weight gain (an indicator of rapid weight gain) at 9 months of age. The responsive parenting approach, delivered by an integrated behavioral health expert, has been culturally adapted for infants and caregivers who are economically marginalized and/or from communities of color through focus groups. The delivery of this intervention via integrated behavioral health in a pediatric primary care setting has the potential to have a significant public health impact in terms of preventing pediatric obesity later in life; and thus, improving health outcomes and reducing health disparities.

Being tested
THRIVE 2.0
Keywords
obesity prevention, infancy, integrated primary care, integrated behavioral health, responsive parenting, responsive feeding, sleep, soothing
Medical subject headings
Obesity, Pediatric Obesity, Weight Gain, Body-Weight Trajectory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • THRIVE 2.0Behavioural

    Overview of content and strategies: 1) Education on stage of development specific to infant feeding, sleep and infant regulation, attunement to cues; 2) Attunement to cues: reinforcing and modeling accurate discernment \& responsiveness to cues; 3) Infant Soothing and Regulation: Coaching alternative strategies for soothing that feeding for non-hungry, fussy infants; 4) Routines \& Strategies: Promoting developmental activities during wake windows and longer consolidated sleep at night as the infant grows.

Study groups in NCT06028113
Study groupRoleWhat they receive
Treatment GroupExperimentalThe Teaching Healthy Responsive Parenting during Infancy to promote Vital growth and rEgulation (THRIVE 2.0) group will consist of 4 sessions delivered by the trained IBH provider, in conjunction with the 1, 2, 4, and 6 month well-child visit in primary care. The THRIVE curriculum teaches responsive parenting principles targeted to establish healthy eating, sleeping, and regulation habits for infants.
Receives: Behavioral: THRIVE 2.0
Control GroupNo interventionControl arm: Usual Pediatric Care. The control condition is usual care delivered by pediatricians at 1, 2, 4, and 6 month well child visits.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Conditional Weight Gain

    Conditional Weight Gain scores will be calculated using length and weight of the infants. Length and weight will be measured in triplicate by masked research-reliable trained assessors and with standardized anthropometric procedures and averaged at each time point. Infants will be weighed unclothed, in a dry diaper using a Scale-Tronix 4802D Infant scale that is calibrated every day. Infant length will be measured using a Pediatric Stadiometer by O'Leary (PED LB35-07-X). Conditional weight gain is calculated as standardized residuals from the linear regression of anthropometric data (e.g., weight and length) on birthweight, with age and sex entered as covariates. Scores closer to 0 are ideal, with scores higher than 0 indicating more rapid weight gain and scores below 1 indicating slower weight gain. Primary outcomes will include conditional weight gain scores at the 9-month post-treatment time point.

    Measured: At infant age 9-months (post-treatment)

Secondary outcomes (14)
  1. Conditional Weight Gain

    Conditional Weight Gain scores will be calculated using length and weight of the infants. Length and weight will be measured in triplicate by masked research-reliable trained assessors and with standardized anthropometric procedures and averaged at each time point. Infants will be weighed unclothed, in a dry diaper using a Scale-Tronix 4802D Infant scale that is calibrated every day. Infant length will be measured using a Pediatric Stadiometer by O'Leary (PED LB35-07-X). Conditional weight gain is calculated as standardized residuals from the linear regression of anthropometric data (e.g., weight and length) on birthweight, with age and sex entered as covariates. Scores closer to 0 are ideal, with scores higher than 0 indicating more rapid weight gain and scores below 1 indicating slower weight gain.

    Measured: At infant age 12 months (follow-up)

  2. The Baby Eating Behavior Questionnaire

    Used to measure infant appetite and contains 5 subscales that assess enjoyment of food, food responsiveness, slowness in eating, and satiety responsiveness, and general appetite. Subscales of the BEBQ have good reliability and the measured appetite traits track throughout infancy and toddlerhood and are related to greater weight gain. Items are scored on a Likert scale ranging from 1 to 5 with higher average scores on each scale indicating more enjoyment of food, food responsiveness, slowness in eating, and satiety responsiveness, respectively.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  3. The Infant Feeding Style Questionnaire

    An 83-item measure of parent feeding beliefs, behaviors, and style with the following subscales: laissez-faire, restrictive, pressuring, responsive and indulgent. Internal reliability measures for the subscales ranged from 0.75 to 0.95. Several sub-constructs, responsive to satiety cues, pressuring with cereal, indulgent pampering and indulgent soothing, were inversely related to infant weight-for-length z-score, meaning higher scores indicate greater risk for obesity.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  4. The Food Frequency Questionnaire

    A validated parent-report measure that assesses infant dietary intake within the previous 7 days. The FFQ measures duration of breast-feeding status, timing of introduction of solid foods, consumption of fruits and vegetables, consumption of proteins, consumption of energy-dense-nutrient-poor foods, and consumption of sugar sweetened beverages. The FFQ correlates well with weighted diaries in infancy. It measures intake across a diverse range of liquid and solid food groups. As infants are gradually introduced to solid foods and become less reliant on milk, the completion time of the measure may increase (requires 5-10 mins to complete).

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  5. Baby Day Diary

    Measures 3 consecutive days of infant feeding, sleeping, and fussy events. The BDD has been extensively validated and administered to families in infant obesity clinical trials. This measure has been adapted to capture frequency (i.e., mean number of feedings per day) and volume of feedings (i.e., mean number of ounces per feeding and solid food consumption) in addition to 24-h sleep frequency and duration across a three day period. Investigators are using the Daily Connect™ app to reduce burden, have the capability to remind parents to complete the logs, and download data more easily. For 3 consecutive days, parents will indicate all infant feeding, sleep, and fussy events. Modified Food Frequency Questionnaire during active treatment: For feeding events, parents will detail whether the infant was fed breast milk, formula, or solids, as well as the number of consumed ounces of formula or breast milk if offered by the bottle.

    Measured: During active treatment at infant age: 2 months, 4 months, and 6 months

  6. Baby Basic Needs Questionnaire

    A 13-item measure assessing parent's use of food to soothe their infant comes from one factor with good internal consistency on The BBNQ asks parents to rate on two different 5-point Likert scales, how likely they would be to use food to soothe in different situations and the perceived effectiveness of using food to soothe in each situation. Higher food-to-soothe scores indicate greater use of food to soothe to quiet, or manage a distressed child in response to a variety of contexts, without regard for whether hunger is the source of infant distress.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  7. The Baby Care Questionnaire

    A 30-item measure of parenting beliefs and practices reflecting structure (regularity of routines) and attunement (recognition of baby cues). Items ask about sleeping, eating, and crying. Items are rated on a 4-point Likert-type scale ranging from strongly disagree (1) to strongly agree (4). Total scores are derived for structure and attunement with higher scores indicating more structure and more attunement.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  8. Infant Behavior Questionnaire - Revised - Very Short Form

    A 37-item measure of infant temperament that is scored using 3 subscales: positive affectivity/surgency, negative emotionality, and orienting capacity. Scores range from 0 to 7, with higher scores representing greater positive affect, negative emotionality and orienting and regulatory capacity.

    Measured: At Infant Age: 9 months (post-treatment)

  9. Brief Infant Sleep Questionnaire - Revised

    A 20-item norm-referenced and validated caregiver-report measure of 4 subscales: infant sleep, parent perception of sleep, parent behavior, and total score. Scales on each subscale and total score are scaled from 0-100 using norm-based referencing. BISQ-R total score is an average of 3 subscales with higher scores denoting better sleep quality, more positive perception of infant sleep, and parent behaviors that promote healthy sleep.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  10. Maternal Self Efficacy

    A 10-item measure of feelings of efficacy in infant care, including soothing, feeding, understanding baby cues, and communicating with baby. Items are endorsed using a Likert scale and a total score is derived. The total score will be used and ranges from 10 to 40 with higher scores representing greater Maternal Self-Efficacy.

    Measured: At infant age 1 month (baseline), 9 months (post-treatment), and 12 months (follow-up)

  11. The Philadelphia Urban Adverse Childhood Experiences (ACES)

    A 22-item measure of caregiver experiences of violence and adversity in childhood. It encompasses the original 10 ACEs and other experiences of trauma and violence associated with growing up in an urban community (e.g., discrimination, unsafe neighborhood). Item-level and total ACEs scores (original) and (Philadelphia ACEs) will be examined in analyses.

    Measured: At infant age 1 month (baseline)

  12. Edinburgh Postnatal Depression Scale (EPDS)

    A 10-item questionnaire was developed to identify women who have postpartum depression and has subsequently been validated as a two-factor measure of postpartum anxiety and depression. The overall assessment is done by total score, which is determined by adding together the scores for each of the 10 items. Higher scores indicate more depressive symptoms.

    Measured: At infant age 1 month (baseline)

  13. Movement Behavior Questionnaire

    A 9-item validated rapid assessment parent-report measure assessing movement behaviors in babies who have yet to reach their walking milestone. The MBQ measures tummy time or active play, restrained time, screen time, and sleep. Scores will be calculated for each individual item by determining the total number of minutes ((hours x 60) + minutes) per day that the baby engages in each type of behavior. Higher scores indicate more time in that activity.

    Measured: At infant age 1 month (baseline, at infant age 9 months (post-treatment), at infant age 12 months (follow-up)

  14. Meals in our Household Questionnaire

    A 47-item validated parent-report measure assessing problematic child mealtime behaviors, use of food as a reward, parental concern about child's diet, and spousal stress related to child's mealtime behaviors. Higher scores indicate more problematic mealtime behaviors, more use of food as a reward, more parental concern about child's diet, and more spousal stress related to child's mealtime behaviors, respectively.

    Measured: At infant age 12 months (follow-up)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2023
  2. Study start5 Oct 2023
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion30 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a Phase 2 pragmatic pilot and feasibility randomized controlled trial (RCT) of an obesity prevention intervention compared to usual pediatric care with 144 mother-infant dyads randomized n=72 per arm. Consistent with the definition of a pilot and feasibility clinical trial, our aims are to assess trial protocol feasibility based on THRIVE 2.0 and obtain effect sizes to inform the design of a Phase 3 multi-site efficacy trial.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06028113
Sponsor's protocol ID
2023-0027
Other IDs
1R01DK135497-01
Acronym
THRIVE
Status last verified
Mar 2025
First submitted
18 Jul 2023
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Prior to sharing, all data will be de-identified in a HIPAA-compliant fashion. Data sets will be carefully reviewed to make sure that information such as age, gender, race, and ethnicity cannot be used to gather additional information that could potentially identify individual subjects. All modalities of data will be shared, including raw and aggregate data. Descriptors for all variables shared will be included to prevent misuse or confusion. Any analytical methods utilized to assess the data will be defined in shared formats. In addition, treatment manuals will also be shared after completion of the trial for future use.

Publications

  • Rybak TM, Francis SE, Mara CA, Zion C, Modi AC, Crosby LE, Herbst RB, Lauer BA, Murphy BN, Harry KR, Patel DJ, Burkhardt MC. THRIVE 2.0: A randomized-controlled trial of an obesity prevention intervention designed for infants in pediatric primary care. Contemp Clin Trials Commun. 2025 Apr 21;45:101488. doi: 10.1016/j.conctc.2025.101488. eCollection 2025 Jun.

    PubMed 40336701

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing THRIVE 2.0 in people with Obesity and Obesity, Childhood, run by Children's Hospital Medical Center, Cincinnati at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tiffany Rybak, PhD (513-517-7254, tiffany.rybak@cchmc.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Conditional Weight Gain (time frame: At infant age 9-months (post-treatment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06028113, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in